Tempus AI (NASDAQ:TEM) Coverage Initiated at Needham & Company LLC

Research analysts at Needham & Company LLC initiated coverage on shares of Tempus AI (NASDAQ:TEM) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set a “buy” rating and a $47.00 price target on the stock. Needham & Company LLC’s price target indicates a potential upside of 34.29% from the company’s previous close.

Other analysts have also issued reports about the company. JPMorgan Chase & Co. began coverage on Tempus AI in a research report on Tuesday. They issued an “overweight” rating and a $42.00 price objective for the company. Loop Capital initiated coverage on shares of Tempus AI in a report on Tuesday. They issued a “buy” rating and a $48.00 price objective on the stock. Finally, TD Cowen assumed coverage on shares of Tempus AI in a report on Tuesday. They set a “buy” rating and a $50.00 target price for the company. Nine equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $45.63.

Tempus AI Stock Up 1.4 %

Shares of TEM opened at $35.00 on Tuesday. Tempus AI has a 52 week low of $22.89 and a 52 week high of $43.88.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.